in a prospective study patients with acute leukemia undergoing remission induction therapy were randomized to receive either a regimen of non-absorbable antimicrobial drugs ( colistin and neomycin ) or of absorbable and non-absorbable drugs ( trimethoprim-sulfamethoxazole [ tmp-smz ] and colistin ) for antibacterial prophylaxis .
C0027603
neomycin
C0279516
antibacterial